|
|
250 South Oak Way
Green Park, Reading RG2 6UG United Kingdom
phone:+44 (0)118 931 5050
fax:+44 (0)118 931 5051
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.archimedespharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Marketing niche pharmaceutical products to the UK market. |
|
| Management |
| Richard de Souza, Chief Executive; Tim Watts, Chief Financial Officer; Charles Marchetti, Group Services and Operations Director; Michael Clark, Group Marketing and Business Development Director; Alan Smith, Ph.D, Vice President, Research & Development |
| |
|
|
| |
|
| Keywords |
| oncology, palliative, gastroenterology, accident, emergency, pharmaceutical, capsules, morphine, psychotic, brain, cancer, Urology, prostate, urinary, bladder, erectile, agents, tumor, surgery |
|
|
|
| Description |
|
Link Pharmaceuticals is dedicated to marketing niche pharmaceutical products to the UK market. Link acquires and licenses innovative products from multinational and development companies. Its strategic focus is on niche areas in oncology, palliative care, gastroenterology and accident and emergency. |
|
| Products / Services |
Lazanda®, PecFent®, Gliadel®, Zomorph®, Oramorph®, Apomorphine injection & Pabrinex®
|
|
| Technology / Differentiation |
| Archimedes Pharma has developed proprietary technologies for nasal and oral drug delivery and currently markets a diverse portfolio of specialty products focused on the oncology, pain, and critical care sectors |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members